ONEMEDNET CORPORATION Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
ONEMEDNET CORPORATION (ONMD) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $9.21 million for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-11-05.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2024-12-17
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2023-12-31 was $822.00K, a 66.02% decline year-over-year.
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2023-09-30 was $4.29M, a 70.51% increase year-over-year.
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2023-06-30 was $2.17M.
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2023-03-31 was $1.94M.
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2023 was $9.21M, a 14.05% increase from fiscal 2022.
- ONEMEDNET CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2022 was $8.07M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|---|---|---|
| 2023-12-31 | $822.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $5.11M derived: sum of 2 quarters · filed 2024-12-17 | $7.27M derived: sum of 3 quarters · filed 2024-12-17 | $9.21M 10-K/A · filed 2024-11-05 |
| 2023-09-30 | $4.29M 10-Q · filed 2024-12-17 | $6.45M derived: sum of 2 quarters · filed 2024-12-17 | $8.38M 8-K/A · filed 2024-11-22 | $10.80M derived: sum of 4 quarters · filed 2024-12-17 |
| 2023-06-30 | $2.17M 10-Q · filed 2024-12-17 | $4.10M derived: sum of 2 quarters · filed 2024-12-17 | $6.52M derived: sum of 3 quarters · filed 2024-12-17 | $9.03M derived: sum of 4 quarters · filed 2024-12-17 |
| 2023-03-31 | $1.94M 10-Q · filed 2024-12-17 | $4.35M derived: sum of 2 quarters · filed 2024-12-17 | $6.87M derived: sum of 3 quarters · filed 2024-12-17 | |
| 2022-12-31 | $2.42M derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $4.93M derived: sum of 2 quarters · filed 2024-11-22 | $8.07M 10-K/A · filed 2024-11-05 | |
| 2022-09-30 | $2.51M 8-K/A · filed 2024-11-22 | $5.65M 8-K/A · filed 2024-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |